Treatment Approach for Chronic Depression

Initial Treatment Approach

The American College of Physicians recommends a combination of pharmacotherapy, such as second-generation antidepressants, and psychotherapy, particularly cognitive behavioral therapy, as the most effective treatment approach for chronic depression, with treatment duration extending beyond 9 months to reduce relapse risk 1, 2
Second-generation antidepressants, such as selective serotonin reuptake inhibitors, are recommended as first-line pharmacotherapy due to their favorable safety profile compared to older antidepressants 1
Psychotherapy options, including cognitive behavioral therapy, interpersonal therapy, and psychodynamic therapies, should be considered alongside medication for chronic depression 1, 2
The choice between different second-generation antidepressants should be based on adverse effect profiles, cost, and patient preferences rather than efficacy, as no single medication has demonstrated superior effectiveness 3

Patient status, therapeutic response, and adverse effects should be assessed regularly, beginning within 1-2 weeks of treatment initiation, with close monitoring for increased suicidal thoughts and behaviors during the first 1-2 months of treatment 3, 4
Response to treatment is typically defined as a 50% reduction in measured severity using tools such as the Patient Health Questionnaire or Hamilton Depression Rating Scale 1
If adequate response is not achieved within 6-8 weeks, treatment modification should be considered 3, 4

After achieving remission, treatment should continue for at least 4-9 months for patients with a first episode of depression 3
For patients with chronic depression or those who have had two or more episodes, longer maintenance treatment, of at least 1 year, is strongly recommended to prevent recurrence 3

Sexual dysfunction is a common side effect with some second-generation antidepressants, while certain medications are associated with lower rates of sexual adverse events 3
Selective serotonin reuptake inhibitors are associated with an increased risk for suicide attempts compared to placebo, necessitating careful monitoring 3

Treatment of chronic depression follows three phases: acute, continuation, and maintenance, with the maintenance phase being particularly important and often needing to be extended beyond standard recommendations 1
Relapse is defined as the return of symptoms during acute or continuation phases, while recurrence refers to symptom return during the maintenance phase 1